Literature DB >> 6124254

Involvement of sulfhydryl groups in the oxidative modulation of particulate lung guanylate cyclase by nitric oxide and N-methyl-N'nitro-N-nitrosoguanidine.

J M Braughler.   

Abstract

Particulate guanylate cyclase from rat lung was activated by nitric oxide or N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) in a dose-dependent manner that was enhanced by dithiothreitol. Nitric oxide-stimulated guanylate cyclase activity decayed during a 60-min preincubation at 37 degrees, but did not decay at 24 degrees or 4 degrees. Dithiothreitol enhanced the decay of nitric oxide-stimulated enzyme at all temperatures by potentiating the reversal of nitric oxide activation. Following the reversal of nitric oxide activation at 24 degrees by dithiothreitol, the particulate enzyme could be reactivated by a second exposure to nitric oxide. Preincubation of basal particulate guanylate cyclase activity at 37 degrees resulted in the loss of enzyme responsiveness to activation by nitric oxide or MNNG that was potentiated by diamide or oxidized glutathione. The inhibitory effects of the thiol oxidants on enzyme responsiveness to activation by MNNG were prevented by dithiothreitol. The results suggest that activation of particulate guanylate cyclase by nitric oxide or MNNG involves the oxidation of key enzyme sulfhydryl groups.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124254     DOI: 10.1016/0006-2952(82)90010-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  2 in total

1.  Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances.

Authors:  W Schmidt; A Walther; M M Gebhard; E Martin; H Schmidt
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

2.  Selective cysteines oxidation in soluble guanylyl cyclase catalytic domain is involved in NO activation.

Authors:  Maryam Alapa; Chuanlong Cui; Ping Shu; Hong Li; Vlad Kholodovych; Annie Beuve
Journal:  Free Radic Biol Med       Date:  2020-11-06       Impact factor: 7.376

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.